Literature DB >> 32884387

Understanding What You Have Found: A Family With a Mutation in the LAMA1 Gene With Literature Review.

Muhsin Elmas1, Basak Gogus1, Mustafa Solak1.   

Abstract

INTRODUCTION: Cerebellar dysplasia with cysts (CDC) is an imaging finding which is typically seen with in individuals with dystroglycanopathy. One of the diseases causing this condition is "Poretti-Boltshauser Syndrome; PTBHS" (OMIM #615960). Homozygous or compound heterozygous mutations in the LAMA1 gene cause this disease. CASE
PRESENTATION: 7 years old twin siblings consulted to the medical genetics department because of walking problems and cerebellar examination findings. MANAGEMENT AND OUTCOME: Clinical and radiological findings of the patient suggested a syndrome with recessive inheritance. Whole exome sequencing (WES) test was performed for definitive diagnosis. As a result of the patient's WES analysis, a homozygous mutation was detected in the LAMA1 gene. DISCUSSION: When determining the inheritance pattern of genetic diseases, if parents have consanquinity, this situation leads us to recessive inheritance diseases. Even if we are not consanquinity, but they say the same village, it is necessary to pay attention to the diseases of the recessive group. Whole exome sequencing analysis results in large amount of data generation. A good clinical evaluation is required to detect the mutation as a result of large data. To understand what we have found, we need to know what we are looking for.
© The Author(s) 2020.

Entities:  

Keywords:  Cerebellar vermis; cerebellar ataxia; laminin

Year:  2020        PMID: 32884387      PMCID: PMC7440728          DOI: 10.1177/1179547620948666

Source DB:  PubMed          Journal:  Clin Med Insights Case Rep        ISSN: 1179-5476


Introduction

Cerebellar malformations cause defective development of the cerebellum and often manifest itself in the first months of life. For some cerebellar malformations, neuroimaging findings are specific and provide diagnosis of disease.[1] However, imaging findings of other cerebellar malformations such as hypoplasia, dysplasia, and cysts are less specific for the disease in which they are components.[2,3] In 2014, “Poretti-Boltshauser Syndrome; PTBHS” (OMIM #615960) is defined by cerebellar cyst and cerebellar dysplasia.[4] This disease also causes myopia with or without retinal dystrophy. Laminins connect basal membranes and extracellular matrix to cell and these are heterotrimeric glycoproteins. At the same time their function is to provide the integrity of the tissue.[5] Of the 12 genes, 9 encoding the laminin subunits are associated with the disease in human.[6-8] One of these genes is the LAMA1 gene encoding Laminin alpha-1. The mutation in this gene causes congenital muscular dystrophy group diseases. In 2014, in the study by Aldinger et al., homozygous or compound heterozygous mutations in this gene were reported to cause “PTBHS.”[4] This disease is very rare. A total of 31 cases (we think 2 of them are repeated and same cases and therefore total number may be 29) of PTBHS have been reported in 4 publications.[4,9-13] In this case report, we aimed to present the clinical findings of the siblings with homozygous mutations in the LAMA1 gene that caused PTBHS.

Case Presentation

Twin boys aged 7 years consulted the medical genetics department with walking problem and cerebellar examination findings. Anamnesis information, examination findings, laboratory results, and genetic test results of twins are summarized in the following.

Patient 1

He was born at 38 weeks of gestation as 2300 g. The 5-minute APGAR score was 8 to 9 points. He started walking at 2 years. At physical examination, head circumference, height, and weight were between 10 and 25 percentile. At the dysmorphic examination, narrow face, pointed chin, hypertelorism, telecanthus, macrotia, smooth philtrum, and thin upper lip vermillion were found. Hypokinesia and dysmetria were detected in the cerebellar examination of the patient. Also, he had ataxia when walking. At ophthalmic examination, he had normal fundus and he had no visual problems. The pathological findings at magnetic resonance imaging (MRI) of the patient are as follows: multiple cysts in millimetric dimensions at both cerebellar hemispheres, irregularities in the cerebellum cortex, cerebellar vermis hypoplasia, and enlargement at fourth ventricle (Figures 1 and 2).
Figure 1.

Brain MR images show cerebellar cyst and enlarged forth ventricle. MR indicates magnetic resonance.

Figure 2.

Brain MR images show cerebellar cyst. MR indicates magnetic resonance.

Brain MR images show cerebellar cyst and enlarged forth ventricle. MR indicates magnetic resonance. Brain MR images show cerebellar cyst. MR indicates magnetic resonance.

Patient 2

In the prenatal period, encephalocele was detected in the seventh month of pregnancy. He was born at 38 weeks of gestation as 1900 g. The 5-minute APGAR score was 6 to 7 points. The encephalocele was excised at 16th day postnatal. The brain tissue and optic nerve were also located in this sac, so these structures were excised too. Hence, he is blind. He had ventriculoperitoneal shunt operation at the ninth month. When he was 5 years old, Botox was injected at the ankles because of spasticity in the lower extremities and tension in the Achilles tendon. He cannot walk still. At physical examination of the patient, his head circumference, height, and weight were under 3 percentile. He had microcephaly. His neck movement had limited extension. At the upper and lower extremities, he had spasticity. At the dysmorphic examination, narrow face, malar flattening, hypertelorism, upslanted palpebral fissure, telecanthus, macrotia, smooth philtrum, and thin upper lip vermillion were found. At ophthalmic examination, he had pale optic disk at the temporal regions in both eyes and he cannot see. At his cranial computed tomography, it was observed that lateral ventricles and third ventricular were collapsed. The parents of these twin siblings have no consanguinity, but they are from the same village. Whole exome sequencing (WES) was performed. As a result of this analysis, the homozygous NM_005559.4 c.8192C>A (p.S2731*) (p. Ser2731Ter) VCV000372974.1 in the LAMA1 gene was detected (ClinVar ID is RCV000413473.1). This mutation is classified as disease causing in MutationTaster and the allele frequency is 0.0000159. In the analysis of the parents, the same mutation was resulted as heterozygous and these were again confirmed by Sanger sequencing. According to the American College of Medical Genetics (ACMG) criteria, this mutation has been reported as “pathogenic.” This is called “PTBHS” (OMIM #615960). Because of the genotype-phenotype similarity of the patients in the literature and our patients, we decided that the diagnosis was PTBHS. Thus, the definitive diagnosis was provided for twin brothers. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article. Ethical approval is not required at our institution to publish an anonymous case report.

Discussion

A total of 12 cases were reported in three publications for PTBHS (summarized in Table 1). Previously, in the study of Micalizz et al., PTBHS patients from Turkey have been reported. We did not include Table 1 because they did not evaluate patients one by one in their articles. In addition, Table 2 summarizes the clinical and MRI findings of patients including the study of Micalizzi et al.
Table 1.

Summary of the literature of the cases of Poretti-Boltshauser Syndrome and our cases.

Aldinger et al[4]Vilboux et al[10]Marlow et al[11]Masson et al[12]Banerjee et al[13]Our Cases
P1P2P3P4P5P6P7P1P2P3P1P2P1P1P1P2
Age36 months36 months25 months29 years23 years5.5 years4.5 years21 years26 years8,5 yearsYounger than 5 yearsYounger than 5 years30 months2.5 years7 years7 years
SexFemaleFemaleMaleFemaleMaleFemaleFemaleMaleFemaleFemaleFemaleMaleFemaleMaleMaleMale
In LAMA1 gene
ZygosityHomozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousCompound heterozygousHomozygousHomozygousHomozygous
Mutationc.588+2T>Gc.6345+3G>C (maternal) and deletion of exons 4-11 (paternal)c.7965-15_7965-3del (paternal) and c.2988_2989delA (maternal)c.6701delC (paternal) and c.8557-1G>C, c.768+1G>A (maternal)c.6701delC (paternal) and c.8557-1G>C, c.768+1G>A (maternal)c.2816_2817delAT (paternal) and c.555T>G (maternal)c.2816_2817delAT (paternal) and c.555T>G (maternal)c.6701delC (paternal) and c.768+1G>A, c.8557–1G>C (maternal)c.6701delC (paternal) and c.768+1G>A, c.8557–1G>C (maternal)c.2160T>A (maternal) and c.5985_5991del (paternal)c.664C>T and c.2331C>Gc.664C>T and c.2331C>Gc.4702_4703delc.8192C>Ac.8192C>A
Protein changeCanonical spliceSplice and NASplice and p.Pro996Hisfs28*p.Pro2334Leufs9* and splice, splicep.Pro2334Leufs9* and splice, splicep.Tyr939Leufs27* and p.Tyr185*p.Tyr939Leufs27* and p.Tyr185*Canonical splice and Pro2234Leufs*9Canonical splice and Pro2234Leufs*9p.Cys720* and p.Ile1996Glufs*7p.Arg222* and p.Tyr777*p.Arg222* and p.Tyr777*p.R2921* and exon 62-63 deletionp.(Leu1568Glyfs*2)(p.S2731*) (p. Ser2731Ter)(p.S2731*) (p.Ser2731Ter)
EthnicityIranianMixed EuropeanMixed EuropeanMixed EuropeanMixed EuropeanAsian and African AmericanAsian and African AmericanUnknownUnknownCaucasian and Native AmericanUnknownUnknownCaucasianUnknownTurkishTurkish
Occipitofrontal circumference50th percentile>98th percentile20th percentile50th percentile30th percentile35th percentile35th percentileNormalNormalUnknownUnknownUnknownUnknown<3 percentile10-25 percentile<3 percentile
Neurodevelopmental featuresModerate motor and speech delayModerate motor delay (no standing or walking), mild speech delayMotor delay (cruising, but no walking), hypotoniaHistory of motor delay, normal speech, normal IQ, college graduate, lives independentlyHistory of motor and speech delay, normal IQ, autism spectrum disorder (Asperger), lives with parentsMild motor and speech delay, hypotoniaMotor and speech delay, hypotoniaHistory of motor and speech delay, graduated high school, mildly wide-based gaitMild motor and speech delays, mildly wide-based gait, graduated from high schoolDelayed motor developmentDelayedDelayedMild motor delayDelayedMild motor delay, hypokinesia and dysmetriaMild motor and speech delays
AtaxiaUnknownUnknownUnknownUnknownUnknownUnknownUnknown+++UnknownUnknown+++Unknown
Autistic featuresUnknownUnknown+Unknown
Strabismus++++++++UnknownUnknownUnknown+
Brain MRI
Cerebellar dysplasia+++++++++++++++The patient has no MRI
Cerebellar cysts+++++++++++++
Vermis hypoplasiaGlobalGlobalGlobalGlobalGlobalInferior onlyInferior only++Global++
Superior cerebellar pedunclesElevated and splayedElevated and splayedNormalElevated and splayedElevated and splayedNormalSlightly elevatedNormalNormalNormalAtrophicAtrophicNormalNormal
Fourth ventricleEnlargedEnlargedEnlargedEnlargedEnlargedMildly enlargedNormalEnlargedEnlargedNormalEnlargedEnlargedEnlargedEnlargedEnlarged
BrainstemShort pons, thin isthmusShort pons, long midbrain, mildly enlarged tectumNormalThin isthmusThin isthmusMass effect from arachnoid cystNormalMidbrain is mildly elongated, pons is mildly reducedElongated midbrain and pons and appearing smallNormalNormalNormalNormalUnknownNormal
VentriclesNormalModerate ventriculomegaly, partial agenesis of corpus callosum and septum pellucidumNormalNormalNormalNormalNormalNormalNormalNormalNormalNormalNormalUnknownNormal
Increased T2/FLAIR in white matterPatchy increased, periventricularPatchy increased, periventricularNormalNormalNormalPatchy increased, periventricularNormalNormalNormalNormalNormalNormalNormalBilateral peritrigonal periventricular white matter changesNormal
OtherAtrophic retina, aminoaciduria, consanguinityThinned retina, seizureAbsent pigment at retinaLattice and peripheral degeneration at retina, macular heterotopia, increased pigment at retina, fatty liver on ultrasound, syndactyly in second and third toesAtrophic retina, bilateral cataracts, echogenic liver on ultrasound, syndactyly in second and third toesRetinal dysfunction: cones more affected than rodsChorioretinal atrophy, macular and peripheral involvement, cones worse than rodsRetinal dystrophy, high myopia, shoulder shrugging and nose wrinkling tics, bilateral syndactyly of the second and third toesShoulder shrugging and nose wrinkling, bilateral syndactyly of the second and third toesPeripheral lattice degeneration of retina and bilateral arm extensions and flexions, nose wrinkling ticsHigh myopiaHigh myopiaHead titubation, occasional motor stereotypes, ocular motor apraxiaMyopiaNormalEncephalocele, spasticity, pale optic disk

Abbreviation: MRI, magnetic resonance imaging.

Table 2.

Clinical and MRI features of cases reported as PTBHS (including our twin patients).

FeaturesNumber of patients (%)
Sex (female)16 of 33 (48)
Ataxia22 of 33 (67)
Strabismus17 of 33 (52)
Neurodevelopmental delay32 of 33 (97)
Myopia12 of 33 (36)
Retinal dystrophy15 of 33 (45)
Cerebellar dysplasia32 of 33 (97)
Cerebellar cysts31 of 33 (94)
Enlarged fourth ventricle27 of 33 (82)
Abnormal brainstem15 of 33 (45)

Abbreviation: PTBHS, Poretti-Boltshauser Syndrome; MRI, magnetic resonance imaging.

Summary of the literature of the cases of Poretti-Boltshauser Syndrome and our cases. Abbreviation: MRI, magnetic resonance imaging. Clinical and MRI features of cases reported as PTBHS (including our twin patients). Abbreviation: PTBHS, Poretti-Boltshauser Syndrome; MRI, magnetic resonance imaging. Previously, cases who are siblings have been reported, but identical twins cases have not been reported and encephalocele finding was also not previously reported in any cases. That may be wrong to think that LAMA1 gene mutation may be the possible cause of encephalocele finding in P2. Because there is an increased risk of congenital cranial malformations in twin cases.[14,15] The compound heterozygous mutation is mostly observed. Previously, only one case reported had a homozygous mutation. At that case, consanguinity between parents was reported. Homozygous mutation was found in our cases too, but their parents had no consanguinity between. However, they were born in the same village. This situation suggests that they have consanguinity from distant ancestors. Therefore, it is very important to ask the patients where their parents are from. Because if they are from the same village, recessive inheritance disease should be considered. At eye examination, most of the patients were found to have eye findings. At the eye examination, in one of our patients, any findings were found (P1). The possible cause of this condition can be considered as this mutation damage eyes less than other mutations. The probable cause of ocular finding in the other twin is encephalocele which develops during intrauterine period. All mutations in a gene that cause a disease do not cause the same clinical findings due to mechanisms such as allelic heterogeneity and variable expressivity in genetic diseases. As shown in Table 1, the age at which PTBHS patients are diagnosed is on a wide range from 25 months to 29 years. The mean age of the patients presented in Table 1 (except our patient) was 10.10. In addition, Micalizzi et al. reported that the average age of follow-up of 17 patients with PTBHS was 7.2 years.[9] MRI findings are present in almost all patients. However, eye examination findings and clinical findings such as ataxia and microcephaly were not reported in all the patients. This situation is an example for a genetic disease that causes a variety of clinical effects even in mutations in the same gene. As seen in our twin patients, although they have the same mutation but their severity for disease are different. Patients with mild clinical findings or with rare clinical findings in the disease may be challenging in diagnosis. In such a case, WES may be a preferable test.

Conclusions

The penetrance of all genetic diseases is different. This makes the diagnosis difficult. it is important to know the patient’s clinical history very well and to evaluate the patient in a multidisciplinary manner.
  14 in total

1.  Cerebellar Cysts and Dysplasias: More Diagnoses to Consider.

Authors:  Arundhati Banerjee; Sameer Vyas; Naveen Sankhyan
Journal:  Pediatr Neurol       Date:  2019-03-11       Impact factor: 3.372

2.  Early-onset head titubation in a child with Poretti-Boltshauser syndrome.

Authors:  Riccardo Masson; Elena Piretti; Serena Pellegrin; Elena Gusson; Andrea Poretti; Enza Maria Valente; Gaetano Cantalupo
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

3.  Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders.

Authors:  K Hasselbacher; R C Wiggins; V Matejas; B G Hinkes; B Mucha; B E Hoskins; F Ozaltin; G Nürnberg; C Becker; D Hangan; M Pohl; E Kuwertz-Bröking; M Griebel; V Schumacher; B Royer-Pokora; A Bakkaloglu; P Nürnberg; M Zenker; F Hildebrandt
Journal:  Kidney Int       Date:  2006-08-16       Impact factor: 10.612

4.  Expression of laminin subunits in congenital muscular dystrophy.

Authors:  C A Sewry; J Philpot; D Mahony; L A Wilson; F Muntoni; V Dubowitz
Journal:  Neuromuscul Disord       Date:  1995-07       Impact factor: 4.296

Review 5.  Congenital abnormalities of the posterior fossa.

Authors:  Thangamadhan Bosemani; Gunes Orman; Eugen Boltshauser; Aylin Tekes; Thierry A G M Huisman; Andrea Poretti
Journal:  Radiographics       Date:  2015 Jan-Feb       Impact factor: 5.333

Review 6.  Cerebellar cysts in children: a pattern recognition approach.

Authors:  Eugen Boltshauser; Ianina Scheer; Thierry A G M Huisman; Andrea Poretti
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

7.  Cystic cerebellar dysplasia and biallelic LAMA1 mutations: a lamininopathy associated with tics, obsessive compulsive traits and myopia due to cell adhesion and migration defects.

Authors:  Thierry Vilboux; May Christine V Malicdan; Yun Min Chang; Jennifer Guo; Patricia M Zerfas; Joshi Stephen; Andrew R Cullinane; Joy Bryant; Roxanne Fischer; Brian P Brooks; Wadih M Zein; Edythe A Wiggs; Christopher K Zalewski; Andrea Poretti; Melanie M Bryan; Meghana Vemulapalli; James C Mullikin; Martha Kirby; Stacie M Anderson; Marjan Huizing; Camilo Toro; William A Gahl; Meral Gunay-Aygun
Journal:  J Med Genet       Date:  2016-01-13       Impact factor: 6.318

8.  Mutations in LAMA1 cause cerebellar dysplasia and cysts with and without retinal dystrophy.

Authors:  Kimberly A Aldinger; Stephen J Mosca; Martine Tétreault; Jennifer C Dempsey; Gisele E Ishak; Taila Hartley; Ian G Phelps; Ryan E Lamont; Diana R O'Day; Donald Basel; Karen W Gripp; Laura Baker; Mark J Stephan; Francois P Bernier; Kym M Boycott; Jacek Majewski; Jillian S Parboosingh; A Micheil Innes; Dan Doherty
Journal:  Am J Hum Genet       Date:  2014-08-07       Impact factor: 11.025

9.  Cerebellar hypoplasia: differential diagnosis and diagnostic approach.

Authors:  Andrea Poretti; Eugen Boltshauser; Dan Doherty
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-05-16       Impact factor: 3.908

10.  Clinical, neuroradiological and molecular characterization of cerebellar dysplasia with cysts (Poretti-Boltshauser syndrome).

Authors:  Alessia Micalizzi; Andrea Poretti; Marta Romani; Monia Ginevrino; Tommaso Mazza; Chiara Aiello; Ginevra Zanni; Bastian Baumgartner; Renato Borgatti; Knut Brockmann; Ana Camacho; Gaetano Cantalupo; Martin Haeusler; Christiane Hikel; Andrea Klein; Giorgia Mandrile; Eugenio Mercuri; Dietz Rating; Romina Romaniello; Filippo Maria Santorelli; Mareike Schimmel; Luigina Spaccini; Serap Teber; Arpad von Moers; Sarah Wente; Andreas Ziegler; Andrea Zonta; Enrico Bertini; Eugen Boltshauser; Enza Maria Valente
Journal:  Eur J Hum Genet       Date:  2016-03-02       Impact factor: 4.246

View more
  1 in total

1.  Recessive LAMA5 Variants Associated With Partial Epilepsy and Spasms in Infancy.

Authors:  Sheng Luo; Zhi-Gang Liu; Juan Wang; Jun-Xia Luo; Xing-Guang Ye; Xin Li; Qiong-Xiang Zhai; Xiao-Rong Liu; Jie Wang; Liang-Di Gao; Fu-Li Liu; Zi-Long Ye; Huan Li; Zai-Fen Gao; Qing-Hui Guo; Bing-Mei Li; Yong-Hong Yi; Wei-Ping Liao
Journal:  Front Mol Neurosci       Date:  2022-05-19       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.